Subscribe To

Price Alert Latest News Economic Calendar News

MET / How Much Upside is Left in MetLife (MET)? Wall Street Analysts Think 34.95%

The average of price targets set by Wall Street analysts indicates a potential upside of 35% in MetLife (MET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Read More

Demo Live Account See Partner Details

Content Topics

Much

Upside

Left

Metlife

MET

Wall

Street

Analysts

Think

met

34 95

Stock

Posted: Apr 11 2023, 11:30

Author Name: Zacks Investment Research

MET News

By Zacks Investment Research
November 2, 2023

MetLife (MET) Q3 Earnings Miss Despite Rising Investment Returns

MetLife (MET) exits the third quarter with cash and cash equivalents of $14.9 billion.

By Zacks Investment Research
November 1, 2023

MetLife (MET) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for MetLife (MET) give a sense of how its business performed in the quarter ended September 2023, it might be worth consi

By Zacks Investment Research
October 19, 2023

MetLife (MET) & Nayya Unite to Enhance Insurance Offerings

MetLife (MET) announces a strategic partnership with Nayya to improve employee benefits experience.

By Zacks Investment Research
October 3, 2023

Should Value Investors Buy MetLife (MET) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe

By Zacks Investment Research
October 2, 2023

MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it tak

By Zacks Investment Research
September 28, 2023

MetLife (MET) Stock Rises 11.8% in 3 Months: More Room to Run?

MetLife's (MET) strong performing U.S. and Asia business, coupled with cost-reduction initiatives, position the company well for growth.

By Zacks Investment Research
September 27, 2023

MET vs. PUK: Which Stock Should Value Investors Buy Now?

Investors with an interest in Insurance - Multi line stocks have likely encountered both MetLife (MET) and Prudential (PUK). But which of these two co

By Zacks Investment Research
September 18, 2023

MetLife (MET) Unveils Solutions to Boost Footprint in Asia

MetLife (MET) launches 360Health in Nepal and 360Future in Korea to empower its clients to effectively manage their health conditions and enjoy a happ

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.